GSK3B and cardiac hypertrophy: It was reported that miRNAs could target GSK3β in some cardiac pathological processes, such as myocardial I/R injury, cardiac hypertrophy, and cardiac fibrosis, which suggested that miRNAs might be involved in glycogen synthesis.